| DC isoketal-modified proteins activate T cells and promote hypertension A Kirabo, V Fontana, APC De Faria, R Loperena, CL Galindo, J Wu, ... The Journal of clinical investigation 124 (10), 4642-4656, 2014 | 512 | 2014 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 435 | 2023 |
| Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans HA Itani, WG McMaster Jr, MA Saleh, RR Nazarewicz, TP Mikolajczyk, ... Hypertension 68 (1), 123-132, 2016 | 250 | 2016 |
| Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase J Wu, SR Thabet, A Kirabo, DW Trott, MA Saleh, L Xiao, MS Madhur, ... Circulation research 114 (4), 616-625, 2014 | 246 | 2014 |
| Oligoclonal CD8+ T Cells Play a Critical Role in the Development of Hypertension DW Trott, SR Thabet, A Kirabo, MA Saleh, H Itani, AE Norlander, J Wu, ... Hypertension 64 (5), 1108-1115, 2014 | 240 | 2014 |
| Immune activation caused by vascular oxidation promotes fibrosis and hypertension J Wu, MA Saleh, A Kirabo, HA Itani, KRC Montaniel, L Xiao, W Chen, ... The Journal of clinical investigation 126 (1), 50-67, 2016 | 231 | 2016 |
| Renal denervation prevents immune cell activation and renal inflammation in angiotensin II–induced hypertension L Xiao, A Kirabo, J Wu, MA Saleh, L Zhu, F Wang, T Takahashi, ... Circulation research 117 (6), 547-557, 2015 | 231 | 2015 |
| Renal Transporter Activation During Angiotensin-II Hypertension is Blunted in Interferon-γ−/− and Interleukin-17A−/− Mice NV Kamat, SR Thabet, L Xiao, MA Saleh, A Kirabo, MS Madhur, E Delpire, ... Hypertension 65 (3), 569-576, 2015 | 212 | 2015 |
| Interleukin-17A regulates renal sodium transporters and renal injury in angiotensin II–induced hypertension AE Norlander, MA Saleh, NV Kamat, B Ko, J Gnecco, L Zhu, BL Dale, ... Hypertension 68 (1), 167-174, 2016 | 197 | 2016 |
| Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation MA Saleh, WG McMaster, J Wu, AE Norlander, SA Funt, SR Thabet, ... The Journal of clinical investigation 125 (3), 1189-1202, 2015 | 163 | 2015 |
| CD70 exacerbates blood pressure elevation and renal damage in response to repeated hypertensive stimuli HA Itani, L Xiao, MA Saleh, J Wu, MA Pilkinton, BL Dale, NR Barbaro, ... Circulation research 118 (8), 1233-1243, 2016 | 155 | 2016 |
| Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat MA Saleh, EI Boesen, JS Pollock, VJ Savin, DM Pollock Hypertension 56 (5), 942-949, 2010 | 148 | 2010 |
| Inhibition of interleukin-17A, but not interleukin-17F, signaling lowers blood pressure, and reduces end-organ inflammation in angiotensin II–induced hypertension MA Saleh, AE Norlander, MS Madhur JACC: Basic to Translational Science 1 (7), 606-616, 2016 | 123 | 2016 |
| A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage AE Norlander, MA Saleh, AK Pandey, HA Itani, J Wu, L Xiao, J Kang, ... JCI insight 2 (13), 2017 | 111 | 2017 |
| Integrative network analysis reveals molecular mechanisms of blood pressure regulation T Huan, Q Meng, MA Saleh, AE Norlander, R Joehanes, J Zhu, BH Chen, ... Molecular systems biology 11 (4), 799, 2015 | 99 | 2015 |
| Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease MA Saleh, JS Pollock, DM Pollock Journal of Pharmacology and Experimental Therapeutics 338 (1), 263-270, 2011 | 91 | 2011 |
| Origin of matrix-producing cells that contribute to aortic fibrosis in hypertension J Wu, KRC Montaniel, MA Saleh, L Xiao, W Chen, GK Owens, ... Hypertension 67 (2), 461-468, 2016 | 83 | 2016 |
| Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes MA Saleh, EI Boesen, JS Pollock, VJ Savin, DM Pollock Diabetologia 54, 979-988, 2011 | 80 | 2011 |
| The rationale for potential pharmacotherapy of COVID-19 M Saber-Ayad, MA Saleh, E Abu-Gharbieh Pharmaceuticals 13 (5), 96, 2020 | 67 | 2020 |
| TFF1 activates p53 through down-regulation of miR-504 in gastric cancer M Soutto, Z Chen, MA Saleh, A Katsha, S Zhu, A Zaika, A Belkhiri, ... Oncotarget 5 (14), 5663, 2014 | 64 | 2014 |
Meena S. MadhurVanderbilt UniversityVerified email at vanderbilt.edu
